{
    "eid": "2-s2.0-85108117546",
    "title": "Direct oral anticoagulants in asian patients with atrial fibrillation: Consensus recommendations by the Asian Pacific Society of Cardiology on strategies for thrombotic and bleeding risk management",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "AF",
        "Asia",
        "Bleeding",
        "Consensus",
        "Haemostasis",
        "Non-vitamin K antagonist oral anticoagulants",
        "Vitamin K antagonist"
    ],
    "authors": [
        "Daniel T.T. Chong",
        "Felicita Andreotti",
        "Peter Verhamme",
        "Jamshed J. Dalal",
        "Noppacharn Uaprasert",
        "Chun Chieh Wang",
        "Young Keun On",
        "Yi Heng Li",
        "Jun Jiang",
        "Koji Hasegawa",
        "Khalid Almuti",
        "Rong Bai",
        "Sidney T.H. Lo",
        "Rungroj Krittayaphong",
        "Lai Heng Lee",
        "David K.L. Quek",
        "Sofian Johar",
        "Swee Chong Seow",
        "Christopher J. Hammett",
        "Jack W.C. Tan"
    ],
    "citedby-count": 13,
    "ref-count": 81,
    "ref-list": [
        "Epidemiology of atrial fibrillation: The Australian and Asia-Pacific perspective",
        "The net clinical benefit of warfarin anticoagulation in atrial fibrillation",
        "Management of patients on non-vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American Heart Association",
        "GRADE guidelines: 3. Rating the quality of evidence",
        "Dabigatran versus warfarin in patients with atrial fibrillation",
        "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation",
        "Apixaban versus warfarin in patients with atrial fibrillation",
        "Edoxaban versus warfarin in patients with atrial fibrillation",
        "Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials",
        "Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis",
        "2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons",
        "Korean guideline of atrial fibrillation management",
        "2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation",
        "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS",
        "Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data",
        "Oral anticoagulants usage in Japanese patients aged 18\u201374 years with nonvalvular atrial fibrillation: a retrospective analysis based on insurance claims data",
        "Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis",
        "Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data",
        "Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation",
        "Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis",
        "Drug class, renal elimination, and outcomes of direct oral anticoagulants in Asian patients: a meta-analysis",
        "Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions",
        "Dabigatran versus warfarin in patients with mechanical heart valves",
        "Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study",
        "The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation",
        "Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation",
        "Ischemic stroke risk in patients with nonvalvular atrial fibrillation: JACC review topic of the week",
        "Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review",
        "Improving CHA(2) DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation",
        "Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation",
        "Dynamic changes of CHA2DS2-VASc Score and the risk of ischaemic stroke in Asian patients with atrial fibrillation: a nationwide cohort study",
        "Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially \u2018low-risk\u2019 patients",
        "Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation",
        "Clinical scales do not reliably identify acute ischemic stroke patients with large-artery occlusion",
        "Age-dependent anticoagulant therapy for atrial fibrillation patients with intermediate risk of ischemic stroke: A nationwide population-based study",
        "Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities",
        "2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)",
        "Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?",
        "Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation",
        "Female sex as a risk modifier for stroke risk in atrial fibrillation: using CHA2DS2-VASc versus CHA2DS2-VA for stroke risk stratification in atrial fibrillation: a note of caution",
        "Stroke risk stratification: CHA2DS2-VA or CHA2DS2-VASc?",
        "Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?",
        "Cardiac Society of Australia and New Zealand (CSANZ). NHFA and CSANZ: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018",
        "Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis",
        "Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study",
        "Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation",
        "Low-dose edoxaban in very elderly patients with atrial fibrillation",
        "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation",
        "Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial",
        "Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial",
        "Non-vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal",
        "Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction",
        "Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation",
        "Label adherence for non-vitamin K antagonist oral anticoagulants in a prospective cohort of Asian patients with atrial fibrillation",
        "Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation",
        "Effectiveness and safety of off-label dosing of non-vitamin K antagonist anticoagulant for atrial fibrillation in Asian patients",
        "Old and new oral anticoagulants: food, herbal medicines and drug interactions",
        "A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines",
        "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY trial analysis",
        "Impact of renal function on outcomes with edoxaban in the ENGAGE AF-TIMI 48 trial",
        "Comparison of the safety and effectiveness of apixaban versus warfarin in patients with severe renal impairment",
        "Safety of edoxaban 30 mg in elderly patients with severe renal impairment",
        "Comparison of renal function estimation formulae for dosing direct oral anticoagulants in patients with atrial fibrillation",
        "Impacts of different renal function estimation formulas on dosing of DOACs and clinical outcomes",
        "Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment",
        "Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and severe kidney disease or undergoing hemodialysis",
        "Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States",
        "RENAL-AF trial interim results",
        "Prevention of bleeding in patients with atrial fibrillation undergoing PCI",
        "Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation",
        "Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation",
        "Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/ acute coronary syndrome patients",
        "Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial",
        "Antithrombotic therapy for atrial fibrillation with stable coronary disease",
        "Risk of thromboembolic events in patients with non-valvular atrial fibrillation after dabigatran or rivaroxaban discontinuation \u2013 data from the Ljubljana registry",
        "Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant",
        "2017 HRS/EHRA/ ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary",
        "Periinterventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry",
        "Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors",
        "Outcomes associated with resuming warfarin treatment after hemorrhagic stroke or traumatic intracranial hemorrhage in patients with atrial fibrillation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Singapore City",
            "@id": "60275486",
            "affilname": "Sengkang General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60275486",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kyoto",
            "@id": "60199421",
            "affilname": "National Hospital Organization Kyoto Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199421",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Abu Dhabi",
            "@id": "60121845",
            "affilname": "Cleveland Clinic Abu Dhabi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60121845",
            "affiliation-country": "United Arab Emirates"
        },
        {
            "affiliation-city": "Rome",
            "@id": "60073799",
            "affilname": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073799",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60073432",
            "affilname": "Beijing Anzhen Hospital, Capital Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073432",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Taoyuan",
            "@id": "60073391",
            "affilname": "Chang Gung University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073391",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Tainan",
            "@id": "60073386",
            "affilname": "National Cheng Kung University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073386",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Bandar Seri Begawan",
            "@id": "60072092",
            "affilname": "Raja Isteri Pengiran Anak Saleha Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60072092",
            "affiliation-country": "Brunei Darussalam"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031325",
            "affilname": "National University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031325",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60029310",
            "affilname": "Zhejiang University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029310",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Brisbane",
            "@id": "60028435",
            "affilname": "Royal Brisbane and Women's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028435",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "3000 Leuven",
            "@id": "60025063",
            "affilname": "KU Leuven",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025063",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60017958",
            "affilname": "Singapore General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017958",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60010400",
            "affilname": "Pantai Holdings Sdn Bhd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010400",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60004409",
            "affilname": "National Heart Centre Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004409",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Mumbai",
            "@id": "107313119",
            "affilname": "Kokilaben Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107313119",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "100839671",
            "affilname": "Liverpool Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100839671",
            "affiliation-country": "Australia"
        }
    ],
    "funding": [
        "Abbott Diagnostics and Beckmann",
        "Orbus Neich and Biotronik",
        "Abbott",
        "Amgen",
        "Bristol Meyers Squibb",
        "Pfizer",
        "AstraZeneca",
        "Bayer",
        "Roche",
        "Sanofi",
        "Medtronic",
        "Boehringer Ingelheim",
        "Boston Scientific",
        "Abbott Vascular",
        "Daiichi Sankyo",
        "BI"
    ]
}